Chip Chambers

Henry F. (Chip) Chambers, M.D.

Co-Editor
  • Professor of Medicine, University of California San Francisco (1992-2018)
  • Professor of Medicine, Emeritus, University of California San Francisco (2018-Present)
  • Chief of Infectious Diseases, San Francisco General Hospital (1992-2013)
  • Director, UCSF Infectious Diseases Fellowship Training Program (2002-2013)
  • Director, Clinical Research Services, Clinical & Translational Science Institute (2013-2020)
  • Editor, American Society for Microbiology’s Antimicrobial Agents and Chemotherapy (2011-2018)

Area of Special Interest

  • Antimicrobial drug resistance, staphylococcal infections, experimental therapeutics and epidemiology and pathogenesis of disease caused by Staphylococcus aureus.

Professional Recognitions & Appointments

  • Co-Chair, IDSA guidelines committee for treatment of MRSA
  • Fellow of the IDSA
  • Fellow American College of Physicians
  • Elected member of the American Society for Clinical Investigation
  • Elected member of the Association of American Physicians

Publication Highlights

Over 300 original publications and textbook chapters in the areas of drug resistance, endocarditis, bacterial infections, and staphylococcal diseases including:

Education

  • Centre College Kentucky (BA)
  • Vanderbilt University (Medical School)
  • University of California San Francisco, School of Medicine (Residency)
  • University of California San Francisco, School of Medicine (Infectious Diseases Fellowship)
  • Microbiology laboratory of Alexander Tomasz, Rockefeller University (Post-doctoral Fellowship)

Disclosures

  • Moderna - Stock
  • Merck - Stock, Member of Data Safety Monitoring Board
  • Lilly - Medical Expert